0.7(top 50%)
impact factor
3.2K(top 10%)
papers
36.2K(top 10%)
citations
66(top 10%)
h-index
0.7(top 50%)
impact factor
3.4K
all documents
37.6K
doc citations
105(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validationInternational Journal of Clinical Pharmacology and Therapeutics20081,203
2A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacologyInternational Journal of Clinical Pharmacology and Therapeutics2002428
3P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugsInternational Journal of Clinical Pharmacology and Therapeutics2000333
4Basic characteristics and representativeness of the German Disease Analyzer databaseInternational Journal of Clinical Pharmacology and Therapeutics2018261
5Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studiesInternational Journal of Clinical Pharmacology and Therapeutics2009237
6Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitisInternational Journal of Clinical Pharmacology and Therapeutics2010213
7Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug useInternational Journal of Clinical Pharmacology and Therapeutics2000206
8Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modellingInternational Journal of Clinical Pharmacology and Therapeutics1997183
9The effect of food on the absorption and pharmacokinetics of rivaroxabanInternational Journal of Clinical Pharmacology and Therapeutics2013166
10Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failureInternational Journal of Clinical Pharmacology and Therapeutics2002160
11Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 – 2002International Journal of Clinical Pharmacology and Therapeutics2007152
12Drug interactions with St. John’s Wort (Hypericum perforatum): a review of the clinical evidenceInternational Journal of Clinical Pharmacology and Therapeutics2004150
13Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban – an oral, direct Factor Xa inhibitor – in healthy subjectsInternational Journal of Clinical Pharmacology and Therapeutics2007150
14Nitazoxanide: pharmacokinetics and metabolism in manInternational Journal of Clinical Pharmacology and Therapeutics2000145
15Gender differences in pharmacokinetics and pharmacodynamicsInternational Journal of Clinical Pharmacology and Therapeutics1999139
16Benfotiamine in the treatment of diabetic polyneuropathy – a three-week randomized, controlled pilot study (BEDIP Study)International Journal of Clinical Pharmacology and Therapeutics2005136
17What do primary care patients think about generic drugs?International Journal of Clinical Pharmacology and Therapeutics2005134
18P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humansInternational Journal of Clinical Pharmacology and Therapeutics2000130
19Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparisonInternational Journal of Clinical Pharmacology and Therapeutics2000129
20Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY StudyInternational Journal of Clinical Pharmacology and Therapeutics2004129
21Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumorsInternational Journal of Clinical Pharmacology and Therapeutics2012126
22Hubble-bubble (water pipe) smoking: levels of nicotine and cotinine in plasma, saliva and urineInternational Journal of Clinical Pharmacology and Therapeutics2002116
23Pharmacokinetics of immunosuppressants: a perspective on ethnic differencesInternational Journal of Clinical Pharmacology and Therapeutics2004114
24Hazardous pharmacokinetic interaction of Saint John’s wort (Hypericum perforatum) with the immunosuppressant cyclosporinInternational Journal of Clinical Pharmacology and Therapeutics2000113
25Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trialsInternational Journal of Clinical Pharmacology and Therapeutics2003112
26Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIbInternational Journal of Clinical Pharmacology and Therapeutics1998112
27Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humansInternational Journal of Clinical Pharmacology and Therapeutics2015111
28Statins differ in their ability to block NF-kB activation in human blood monocytesInternational Journal of Clinical Pharmacology and Therapeutics2003111
29Pharmacological insights from P-glycoprotein knockout miceInternational Journal of Clinical Pharmacology and Therapeutics1998110
30The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemiaInternational Journal of Clinical Pharmacology and Therapeutics2000103
31Predictability of the effects of race or ethnicity on pharmacokinetics of drugsInternational Journal of Clinical Pharmacology and Therapeutics2000101
32Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problemInternational Journal of Clinical Pharmacology and Therapeutics2006100
33A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humansInternational Journal of Clinical Pharmacology and Therapeutics200198
34Infliximab in chronic ocular inflammationInternational Journal of Clinical Pharmacology and Therapeutics200597
35DNA repair in resistance to alkylating anticancer drugsInternational Journal of Clinical Pharmacology and Therapeutics200296
36The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patientsInternational Journal of Clinical Pharmacology and Therapeutics199695
37Pharmacokinetics and bioavailability of the flavonol quercetin in humansInternational Journal of Clinical Pharmacology and Therapeutics199993
38Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosisInternational Journal of Clinical Pharmacology and Therapeutics200292
39Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumorsInternational Journal of Clinical Pharmacology and Therapeutics200292
40Effects of obesity on the cytochrome P450 enzyme systemInternational Journal of Clinical Pharmacology and Therapeutics199992
41Effect of food on the pharmacokinetic profile of trans-resveratrolInternational Journal of Clinical Pharmacology and Therapeutics200891
42First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymesInternational Journal of Clinical Pharmacology and Therapeutics200390
43Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parametersInternational Journal of Clinical Pharmacology and Therapeutics200589
44P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compoundInternational Journal of Clinical Pharmacology and Therapeutics199887
45An extract of Petasites hybridus is effective in the prophylaxis of migraineInternational Journal of Clinical Pharmacology and Therapeutics200085
46The MDR1 3435 polymorphism in patients with rheumatoid arthritisInternational Journal of Clinical Pharmacology and Therapeutics200485
47Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjectsInternational Journal of Clinical Pharmacology and Therapeutics200483
48Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteersInternational Journal of Clinical Pharmacology and Therapeutics199883
49Population pharmacokinetic meta-analysis with efavirenzInternational Journal of Clinical Pharmacology and Therapeutics200282
50Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimenInternational Journal of Clinical Pharmacology and Therapeutics200582